A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.
Are researchers able to access trial data? Audit provides insights on data sharing from industry-sponsored studies
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
A recent article from Science explores how meta-analyses may be less authoritative than they seem.
The Wellcome Trust announces a new open access policy, which includes five key updates.
Journals and funders pledge to publish peer review reports in a move to increase transparency of the publication process.
Tim Koder reviews the potential for ORCiD, CRediT and Convey to increase transparency and accountability in medical publishing.
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
eLife is trialling a novel form of open peer review that gives authors more control over their response to reviewers.
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Learn more about the potential impact of cOAlition S: a commitment to make all European publicly funded research freely available by 2020.
Get up to speed with the latest tips for increasing patient involvement in publications from Elevate Magazine.
In a recent publication, researchers examine whether funder open access platforms are a good idea.
Robert-Jan Smits, a senior European Commission official comments on whether open access for all scientific papers by 2020 is a realistic goal.
The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
CBI’s Publication Planning Meeting is back by popular demand with new dates and an exciting new programme.
In a recent MAP newsletter, ISMPP share an update from ASCO on their new open access option for industry-funded research.